Our Orthopaedic portfolio provides our customers with a comprehensive range of surgical solutions, from Primary Total Joint replacement to solutions for extensive revision surgery.
Our Orthopaedic Products
Medacta has pioneered minimally invasive surgical techniques, in particular its Anterior Minimally Invasive Surgery (“AMIS”) approach for hip replacements. With Medacta’s patient-matched, 3D printed technology, Surgeons can offer patients solutions tailored to their anatomy allowing for greater accuracy.
Suplasyn® is indicated as a viscoelastic supplement for small synovial joints. It is administered intra-articularly into the synovial space of affected joint (e.g. knee, hip, toe, ankle, thumb). Suplasyn® has been shown to be beneficial in osteoarthritis for the management of pain and improvement in physical function of joints.
Until now, Platelet Rich Plasma (PRP) systems were unable to sustain the mononuclear cell population while eliminating the RBC and neutrophils. However, Tropocells® advanced gel separation technology removes the cells that promote inflammation and catabolism while producing a solution rich in platelets and monocytes optimising healing and growth.
CONTACT US TODAY